BRCA1 and neoplasm: Due to its broad anti-tumor efficacy in most solid tumors, this novel combination therapy should be applicable to other cancer stem cells and tumors; 2) PARPi-ionizing radiation (IR) combination; Nuclear localization is required for BRCA1 to participate in HR-mediated DNA repair [128].